How Brain-Signalling Systems Affect Autistic and Non-Autistic Brain Networks
Original title: The Pharmacologically Diverse Human Brain: How Neurosignalling Systems Regulate Neurotypical and Neurodivergent Resting-State Networks
Researchers examined how several signalling systems—including serotonin, dopamine, cannabinoids, opioids, glutamate and GABA—affect resting-state brain-network connectivity in autistic and non-autistic people.
Their findings suggest that networks showing baseline differences in autistic participants, including sensory and attention networks, may also respond differently to certain pharmacological challenges. Responses were not uniform, highlighting the substantial variation among individuals.
Why we referenced it
This abstract provides an example of how researchers investigate differences in neural connectivity and signalling between autistic and non-autistic brains.
Important context
This is a conference abstract, not a complete research paper. It concerns autism specifically and should not be generalized to every form of neurodivergence.